Skip to main content

Jury Awards Plaintiff $37 Million After a Mesothelioma Trial

Jury Awards Plaintiff $37 Million After a Mesothelioma Trial

Jury Awards Plaintiff $37 Million After a Mesothelioma Trial

Introduction

The Mesothelioma trial running for over two months has finally ended with a jury ordering J&J and its talc supplier to cough up $37 million as compensatory damages. The case was filed by a man and his wife seeking compensation for his diagnosis of mesothelioma (a cancer of the lung) allegedly caused by the inhalation of asbestos present in the company’s Talcum Powder used over decades. The jury was allotted time by Superior Court Judge Ana C. Viscomi to return for punitive damages in this matter.

Though the defense counsel argued that there was no asbestos in talc evident by the reports of consistent testing using the most reliable and the best technology and methodologies available. However, the jurors concluded that the plaintiff was exposed to asbestos from using J&J's baby powder and/or Shower to Shower powder between 1972 and 2003 and that such exposure was a substantial factor in causing his illness.

J&J and Imerys maintained during the trial that the talcum powder products did not contain asbestos. The case was heard in the Superior Court of the State of New Jersey, County of Middlesex.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!